Friday 14 March 2014

Small research focused companies to be the backbone of improved drugs

Need for innovative therapies for challenging diseases continues to grow and this is accelerating the pace of drug development. Innovation and improved drugs therapies through new technology platforms are expected to flow from the backyards of small research focused companies in coming years.


In 2012 sarepta therapeutics Inc made a 554% return on their investments in biotech research. The reliability of small research firms for future innovation within the sector and optimism is expected to penetrate further into companies with new technology platforms. 


Small pharma and biotech companies will be the future of innovation and research producing improved drugs on low budgets. There is still a need for further innovation within the sector. Market Intelligence is critical in providing valuable insight into current market situation, in-depth company analysis and identifying market opportunities.

For more details on the trend in drug approvals, upcoming milestones and M&A in coming years please see: Global Pharmaceutical and Biotechnology Outlook 2013: Rising Stars.

About The Industry Report Store:
The Industry Report Store is one of the world’s most comprehensive libraries of market intelligence, with the perfect report for every business need at every budget. Business information is paramount for companies seeking to stay ahead amid challenging economic conditions and intense competition. Contact us today to take advantage of our premium intelligence insights and keep up with your industry competitors.

Kundan Sharma
Marketing


T: +44(0)20 3220 0810
M:  kundan.sharma@industryreportstore.com
Headquarters: John Carpenter House, John Carpenter Street London, EC4Y 0AN, United Kingdom

Why not take a moment to browse our new site www.industryreportstore.com. We cover over 50 industries, 130 countries and include over 30,000 company profiles.

Follow us:

No comments:

Post a Comment